Publications by authors named "Ingrid Lindberg"

Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease that is associated with allergic comorbidities. However, studies examining comorbidities in childhood AD are incomplete, which may contribute to suboptimal care.

Objective: The objective was to compare the risk of developing different allergic and non-allergic comorbidities among children with AD to that of a matched non-AD reference cohort in Sweden.

View Article and Find Full Text PDF

Background: Psoriasis is a chronic, autoimmune-mediated inflammatory disorder. Drug persistence is a composite measure of effectiveness, safety, and treatment satisfaction, often estimated using data from administrative databases and clinical registries. Persistence rates calculated from these two data sources appear to be systematically different.

View Article and Find Full Text PDF

Introduction: The use of real-world data offers a possibility to perform large-scale epidemiological studies in actual clinical settings. Despite their many advantages, administrative databases were not designed to be used in research, and the validation of diagnoses and treatments in administrative databases is needed. The primary objective of this study was to validate an existing algorithm based on dispensed prescriptions and diagnoses of skin conditions to identify pediatric patients with atopic dermatitis (AD), using a diagnosis of AD in primary care as a gold standard.

View Article and Find Full Text PDF
Article Synopsis
  • Ustekinumab and secukinumab are shown to have different effectiveness in maintaining treatment in patients with psoriatic arthritis (PsA) compared to adalimumab, with ustekinumab generally resulting in better persistence.
  • A study analyzed data from over 4,600 treatment exposures among nearly 4,000 PsA patients to compare non-persistence rates using statistical models and methods.
  • Risk factors for lower drug persistence included being female, having axial involvement, recent disease onset, and prior biologic treatment experience, highlighting the importance of considering these factors in treatment planning.
View Article and Find Full Text PDF

The incidence of psoriatic arthritis in patients with psoriasis is unclear; existing estimates differ by a factor of ten. Complete population-level data is needed to provide accurate estimates with high confidence. A total of 123,814 adults with psoriasis, free from pre-existing psoriatic arthritis, were identified in population-based data from secondary care in Sweden during 2007 to 2017.

View Article and Find Full Text PDF